Therapeutic targets and pharmacological mechanisms of Coptidis Rhizoma against ulcerative colitis: Findings of system pharmacology and bioinformatics analysis

Evidence of the advantages of Coptidis Rhizoma (CR) for the treatment of ulcerative colitis (UC) is accumulating. However, research revealing the targets and molecular mechanisms of CR against UC is scarce. In this research, a bioinformatics analysis was performed to carry out the physicochemical pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yuanming, Hua, Yiwei, Chen, Weihuan, Zheng, Huan, Wu, Haomeng, Qin, Shumin, Huang, Shaogang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9748441/
https://www.ncbi.nlm.nih.gov/pubmed/36532769
http://dx.doi.org/10.3389/fphar.2022.1037856

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9748441/
https://www.ncbi.nlm.nih.gov/pubmed/36532769
http://dx.doi.org/10.3389/fphar.2022.1037856

Ejemplares similares